PENETRATION OF LIPID MONOLAYERS BY PSYCHOACTIVE DRUGS.
D001923:Brain Chemistry; D002463:Cell Membrane Permeability; D002554:Cerebrosides; D002746:Chlorpromazine; D005732:Gangliosides; D054709:Lecithins; D008055:Lipids; D008468:Meclizine; D008620:Meprobamate; D009966:Orphenadrine; D010634:Phenobarbital; D010713:Phosphatidylcholines; D010714:Phosphatidylethanolamines; D011619:Psychotropic Drugs; D012106:Research; D012110:Reserpine; D013109:Sphingomyelins
D002554:Cerebrosides; D005732:Gangliosides; D054709:Lecithins; D008055:Lipids; D010713:Phosphatidylcholines; D010714:Phosphatidylethanolamines; D011619:Psychotropic Drugs; D013109:Sphingomyelins; D008468:Meclizine; D012110:Reserpine; D008620:Meprobamate; D009966:Orphenadrine; D002746:Chlorpromazine; D010634:Phenobarbital
BRAIN CHEMISTRY; CELL MEMBRANE PERMEABILITY; CEPHALINS; CEREBROSIDES; CHLORPROMAZINE; EXPERIMENTAL LAB STUDY; GANGLIOSIDES; LECITHINS; MECLIZINE; MEPROBAMATE; ORPHENADRINE; PHENOBARBITAL; RESERPINE; SPHINGOMYELINS